Built-in touch screen acquires images directly onto the device and transmits to PACS without a PC.
Aspenstate announced Tuesday it has received clearance from the U.S. Food & Drug Administration for its portable X-ray system, AiRTouch.
This system, developed by Aspsenstate’s parent company, Livermoretech Korea, is the first portable X-ray system on the market with a built-in touchscreen workstation. It is designed, according to a company statement, as an efficient front-line tool for acquiring chest X-rays for COVID-19 diagnoses.
Based on company information, the AiRTouch is light-weight at 5.5 lbs. Its battery fully charges within two hours and can capture up to 300 exposures during a single charge.
AiRTouch differs from other portable X-ray systems, company officials said, because it acquires images directly to the device and can wirelessly transmit them to the PACS through the machine’s built-in workstation. The built-in PC also allows for remote diagnostics and service, maximizing the functional time of the machine and eliminating the need for service calls.
To date, it has been effective in drive-through screening centers in South Korea, said David Lee, Aspenstate vice president and chief operating officer.
“Our clients have noticed a dramtic increase in capacity and the ability to move patients through quickly and efficiently,” he said in a press statement. “They find that the device is very simple to use, and the integrated software and portable features allow them to work outside of the limitations of traditional X-ray solutions.”
AiRTouch also offers other applications, including imaging for urgent care, ambulances, sports medicine, extremities, dental, veterinary, and equine purposes.
Study: AI Bolsters Sensitivity for Pneumothorax on CXR and Significantly Reduces Reporting Time
October 30th 2024For clinically actionable pneumothorax, an artificial intelligence algorithm demonstrated a 93 percent AUC and a 96 percent specificity rate in a study involving chest X-rays from over 27,000 adults.
Comparative Study Evaluates AI Products for Detecting Tuberculosis on Chest X-Rays
August 9th 2024At a 90 percent threshold for sensitivity, Lunit’s Insight CXR and the Nexus CXR software from Nexus demonstrated the highest specificity rates for tuberculosis (TB) detection in a patient population with a high prevalence of TB and HIV.